By hijacking the ubiquitin-proteasome system (UPS), BET PROTACs selectively and completely induce degradation of BET proteins in cancer cells, and thus represent a more efficient strategy for targeting BET proteins12–15. The gene discussed is DNER; the disease is cancer.